| Summary of Segment Loss Including Segment Expenses |
The table below is a summary of the segment loss, including significant segment expenses (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended June 30, |
|
|
Six months ended June 30, |
|
|
|
2026 |
|
|
2025 (1) |
|
|
2026 |
|
|
2025 (1) |
|
|
|
(in thousands) |
(in thousands) |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Research, development, and laboratory |
|
$ |
10,591 |
|
|
$ |
8,962 |
|
|
$ |
20,649 |
|
|
$ |
21,053 |
|
Facility costs |
|
|
10,365 |
|
|
|
10,856 |
|
|
|
20,844 |
|
|
|
22,573 |
|
Support functions |
|
|
6,911 |
|
|
|
6,901 |
|
|
|
14,179 |
|
|
|
15,070 |
|
Stock-based compensation |
|
|
5,342 |
|
|
|
6,629 |
|
|
|
11,004 |
|
|
|
13,651 |
|
Technical operations and manufacturing |
|
|
5,647 |
|
|
|
4,511 |
|
|
|
9,633 |
|
|
|
11,948 |
|
Other(2) |
|
|
2,651 |
|
|
|
2,243 |
|
|
|
5,379 |
|
|
|
4,480 |
|
Research and development related success payments and contingent consideration |
|
|
23,913 |
|
|
|
10,262 |
|
|
|
32,346 |
|
|
|
12,219 |
|
Impairment of long-lived assets |
|
|
- |
|
|
|
44,611 |
|
|
|
- |
|
|
|
44,611 |
|
Total operating expenses |
|
|
65,420 |
|
|
|
94,975 |
|
|
|
114,034 |
|
|
|
145,605 |
|
Loss from operations |
|
|
(65,420 |
) |
|
|
(94,975 |
) |
|
|
(114,034 |
) |
|
|
(145,605 |
) |
Interest income, net |
|
|
1,129 |
|
|
|
577 |
|
|
|
2,080 |
|
|
|
1,569 |
|
Other income, net |
|
|
656 |
|
|
|
598 |
|
|
|
1,109 |
|
|
|
847 |
|
Net loss |
|
$ |
(63,635 |
) |
|
$ |
(93,800 |
) |
|
$ |
(110,845 |
) |
|
$ |
(143,189 |
) |
(1) Certain amounts for the three and six months ended June 30, 2025 have been reclassified to conform to the presentation as of the three and six months ended June 30, 2026. (2) Other includes licensing costs, consulting fees, insurance, and business taxes for the three and six months ended June 30, 2026 and 2025.
|